As part of its plan to introduce e-governance, the Maharashtra Food and Drug Administration (FDA) will soon introduce a new software which will be beneficial for thousands of drug manufacturers spread across the state as they can access all drug related information and status of pending works through online thereby saving a lot of time and energy.
The software will have several user-friendly features and the manufacturers do not have to visit the FDA office frequently as they can access everything online regarding drug manufacturing processes. The other features include process of additional products, certification of the products required for manufacturing purpose and any pending approvals of manufacturers, etc.
O S Sadhwani, joint commissioner, Maha FDA said “Gujarat Food & Drugs Control Administration (FDCA) is already using this software and if they are successful then we will use it across Maharashtra. We are at the primary stage of starting a software which will prove to be beneficial for the manufacturers. There are further talks regarding the meeting with National Informatics Centre (NIC) for the use of the software and for further developments we will follow the path of Gujarat FDCA as it has already implemented it in Gujarat.”
Sadhwani added that Maharashtra FDA had already approached NIC to develop software for online facility for granting licenses to the pharmacists across Maharashtra which was a successful initiative that helped the retailers to save time while applying for licenses and renewals. Likewise by introducing this software FDA is hopeful that it will help manufacturers to complete their pending work.
In the first stage, the Maharashtra FDA will be implementing this software in Konkan division which comprises Thane, Ratnagiri, Raigad and Sindhudurg. After launching this software in Konkan , then it will be used by manufacturers across Maharashtra for a specific period of time. This will help the manufacturer to analyse and complete their pending work or understand what are the need for manufacturing purpose.
As of now the FDA will focus on building the data, but in future they are hoping to continue and will be concentrating on developing the software for manufacturers and most importantly to get the right information about the pending products and approvals.
